Business Context and Reporting Period
OrthoPediatrics Corp. (KIDS) filed this Form 8-K on January 6, 2022, reporting events occurring on January 4, 2022. The Company is a Delaware corporation incorporated in 2017, with principal executive offices in Warsaw, Indiana. The filing addresses a material amendment to its existing debt facility.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or liquidity metrics. It specifically details the terms of a debt instrument amendment:
- Debt Facility: Fourth Amended and Restated Loan and Security Agreement with Squadron Capital LLC.
- Previous Interest Rate: Greater of (a) 3-month LIBOR plus 8.61% or (b) 10.0%.
- New Interest Rate: Greater of (a) 6-month SOFR plus 8.69% or (b) 10.0%.
Material Changes
The primary material change is the transition of the interest rate benchmark from LIBOR (London Interbank Offered Rate) to SOFR (Secured Overnight Financing Rate). Additionally, the reference period for the variable rate component changed from a three-month term to a six-month term, and the spread increased slightly from 8.61% to 8.69%.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the implications of the interest rate change. The amendment was executed to align with the global transition away from LIBOR. The filing notes that the description of the amendment is qualified by the full text of the agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the total outstanding principal balance under the Loan and Security Agreement to assess the impact of the rate change.
- Review Exhibit 10.1 for any additional covenants, fees, or prepayment penalties associated with the Third Amendment.
- Monitor the spread between 6-month SOFR and the previous 3-month LIBOR to estimate future interest expense volatility.
- Confirm if the 10.0% floor rate will be the effective rate given current market conditions.